Dapagliflozin Open Ring Impurity
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

2100872-88-4Dapagliflozin Open Ring Impurity

● In Stock

Catalogue No.:VL1650016
CAS No.:2100872-88-4
Mol. Formula:C21H27ClO7
Mol. Weight:426.89 g/mol

Additional information on CAS 2100872-88-4

Parent drug

Dapagliflozin

IUPAC Name

1-C-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol

Synonyms

N/A

Description

Dapagliflozin Open Ring Impurity (CAS No.: 2100872-88-4) or 1-C-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol is a metabolite of Dapagliflozin which is a highly effective and selective sodium-glucose cotransporter-2 blocker used around the globe for the treatment of type 2 diabetes (T2D). It possesses antihyperglycaemic, cardioprotective and somewhat renoprotective properties.

References

“Formulation of Amorphous Ternary Solid Dispersions of Dapagliflozin Using PEG 6000 and Poloxamer 188: Solid-State Characterization, Ex Vivo Study, and Molecular Simulation Assessment.” Drug Development and Industrial Pharmacy, 2020, www.tandfonline.com/doi/abs/10.1080/03639045.2020.1802482.?Dhillon, Sohita. “Dapagliflozin: A Review in Type 2 Diabetes.” Drugs, vol. 79, no. 10, June 2019, pp. 1135–46, https://doi.org/10.1007/s40265-019-01148-3.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url